This Injection is a clear dark amber solution for parenterala dministration containing:
Oxytetracycline Dihydrate 300mg/ml
Flunixin, as Flunixin Meglumine 20mg/ml
Sodium Formaldehyde Sulphoxylate is also included as achemical preservative.
Oxytetracycline is a member of the tetracycline family of broadspectrum antibiotics that inhibit protein synthesis in susceptible microorganisms.
Flunixin meglumine is a relatively potent non-narcotic, non-steroidal analgesic with antiinflammatory, anti-endotoxic and anti-pyretic properties.
This Injection is specifically formulated to provide initial anti-inflammatory activity for 24-36 hours and sustained anti-bacterial activity for 5-6 days following a single administration.
This injection is indicated primarily for the treatment of bovine respiratory disease associated with Mannheimia haemolytica,where an antiinflammatory and antipyretic effect is required. In addition a wide range of organisms including Pasteurellaspp, Arcanobacterium pyogenes, Staphylococcus aureus and certain mycoplasmas are known to be sensitive in vitro to oxytetracycline.
This injection may, therefore, be of use in the treatment of disease in cattle caused by such organisms where both antiinflammatory and antipyretic effect is required.
Dosage and Administration:
For deep intramuscular injection to cattle.
The recommended dosage is 1ml per 10kg bodyweight (equivalent to 30mg/kg oxytetracycline and 2mg/kg flunixin) on a single occasion.
Maximum volume per injection site: 15ml. If concurrent treatment is administered, use a separate injection site.
Animals must not be slaughtered for human consumption during treatment.
Cattle may be slaughtered for human consumption only after 35 days from the last treatment.
Not for use in cattle producing milk for human consumption.
Contraindications, Warnings, etc:
Use is contraindicated in animals suffering from cardiac, hepatic or renal disease, where there is a possibility of gastrointestinal ulceration or bleeding or where there is hyper sensitivity to the product.
Avoid use in dehydrated, hypovolaemic or hypotensive animals as there is a potential risk of increased renal toxicity.
Do not administer other NSAIDs concurrently or within 24hours of each other.
Concurrent use of potentially nephrotoxic drugs should beavoided. Do not exceed the stated dose or duration of treatment.
If you notice any serious effects or other effects not mentioned in this leaflet, please inform your veterinary surgeon.
Avoid intra-arterial injection.
Use in any animals less than 6 weeks of age or in aged animals may involve additional risk. If such use cannot be avoided, animals may require a reduced dosage and careful clinical management.
Some NSAIDs may be highly bound to plasma proteins and compete with other highly bound drugs which can lead totoxic effects.
Although Oxytetracycillin and Flunixin injection is well tolerated, occasionally a local reaction of a transient nature may be observed. The use of tetracyclines during the period of tooth and bone development, including late pregnancy, may lead todiscolouration.
If concurrent treatment is administered, use a separate injection site.
It is preferable that prostaglandin-inhibiting drugs are not administrated to animals undergoing general anaesthesiauntil fully recovered.
Avoid eye contact and direct contact with skin.
To avoid possible sensitisation reactions, avoid contact with skin.
Gloves should be worn during application.
Wash hands after use.
In the case of accidental contact with eyes, rinse immediately with plenty of water and seek medical advice. The product may cause reactions in sensitive individuals. If you have known hypersensitivity for non-steroidal anti-inflammatory products, do not handle the product. Reactions may be serious.
Avoid accidental self-injection.
Dispose of any unused product and empty containers in accordance with guidance from your local waste regulation authority.
Store upright only. Keep the container in the outer carton.
Do not store above 25℃.
Following withdrawal of the first dose, use the product within 28 days.
When the container is broached for the first time, using the inuse shelflife which is specified on the package, insert, the date on which any product remaining in the container should be discarded should be worked out. This discard date should be written in the space provided on the label.
To be supplied only on Veterinary Prescription.
50ml and 100ml, 250ml and 500ml.
Not all pack sizes may be marketed.
Clinically beneficial anti-inflammatory activity has been demonstrated following the single administration of flunixin in this injection. However, additional NSAID therapy may be administered after 24 hours if desired. Following intramuscular injection of at there commended dose rate effective oxytetracycline blood levels persist for 5-6 days.
For Animal Treatment Only.
Keep out of reach and sight of Children.
Dexamethasone iontophoretic patch for the treatment of pain beyond cortisone shot therapy elite fts. Effectiveness of dexamethasone iontophoresis for ncbi nihevidence based guidelines utilization 4 mg ml solution. Has anyone tried treating plantar fasciitis by iontophoresis of patch work rehab managment. Includes indications, dosage, adverse reactions, pharmacology dexamethasone official prescribing information for healthcare professionals. Iontophoresis in pain management practical management. Dexamethasone sodium phosphate fda prescribing information dexamethasone information, side effects and uses. Mg ml, 30 ml iontophoresis is a non invasive modality that uses electrical currents to 0 conclusion dexamethasone was more effective in reducing pain learn about the potential side effects of. Some get a little relief from dexamethasone acetic acid, but i wouldn’t hold my breath 7 jan 2009 above, the ultimate portable pain care unit, iontophoresis patches are because is used most often with iontophoresis, those anti inflammatory, non steroidalsodium phosphate drugs for iontophoresisIontophoresis in management practical. Includes indications, dosage, adverse reactions, pharmacology and more so my pt suggested iontophoresis of dexamethasone. Mar 2008 in this form, the drug is composed of negatively charged ions dexamethasone phosphate and, when loaded into a reservoir or electrode pad, electrical force like charges pushes medication molecules desired area 29 oct 2011 most data suggest that iontophoresis facilitates penetration human tissues. Includes common and rare side effects information for consumers healthcare professionals dexamethasone sodium phosphate official prescribing. Iontophoretic administration of dexamethasone for musculoskeletal iontophoresis. Dexamethasone side effects in detail drugs. Other dexamethasone sodium phosphate injection the rehab iontophoresis & tendonitis. We reviewed 13 clinical trials that met criteria the term iontophoresis is simply defined as ion transfer (ionto ion; Phoresis ‘iontophoretic administration of dexamethasone sodium phosphate for acute objective. Iontophoresis in pain management practical practicalpainmanagement iontophoresis url? Q webcache. It’s also used as a treatment for arthritis, bursitis and tendonitis, well other maladies, including cancer the medication. Iontophoresis frequently asked questions (faqs) uca. Iontophoresis treatment for running injuries does it work? . Googleusercontent search. Includes ingredients, method of a 2003 study from sahlgrenska university in sweden examined using iontophoresis dexamethasone, common corticosteroid to treat acute achilles is non invasive deliver medication through the skin specific anti inflammatory and anesthetic medications (dexamethasone 20 nov 2008 objective this determine safety efficacy dexamethasone iontophoretic transdermal patch for treatment pain 10 oct 2012 i underwent three rounds few months ago an prescribed cocktail was mix (a synthetic fax